Abstract:The need for new antimicrobials is indisputable. The flight from natural products in drug discovery was unfortunate; however, the revolution that is genome mining, enabled by the explosion in sequencing technology, is a cause for hope. Nevertheless, renewed search and discovery is still a challenge. We explore novel metabolite diversity and the challenges in Streptomyces. Estimating the extent of novel bioactive metabolites remaining to be discovered is an important driver for future investment. Frequent re-discovery of known natural products was a major factor in big pharma exiting search and discovery, and remains a reality. We explore whether this is due to exhaustive isolation and frequent lateral gene transfer. Analysing all biosynthetic gene clusters across all genomes is challenging. Therefore, representative examples of the patterns of secondary metabolite diversity suggest that re-discovery is linked to frequent expression in frequently isolated (and frequently misidentified) strains. Lateral gene transfer of complete biosynthetic clusters is less frequent than might be perceived but frequent gene exchange implies a massive combinatorial biosynthesis experiment. Genome sequencing emphasises rare expression of many secondary metabolite gene clusters and diversification at the finest levels of phylogenetic discrimination. In addition, we are only just beginning to unravel the impact of ecology. The hidden diversity suggests that cluster cloning and heterologous expression in microbial cell factories will explore this diversity more effectively.

Mini review: Genome mining approaches for the identification of secondary metabolite biosynthetic gene clusters in Streptomyces

[Advances of Genome and Secondary Metabolism in Streptomyces].

Thirty complete Streptomyces genome sequences for mining novel secondary metabolite biosynthetic gene clusters

Synthetic Biology Tools for Novel Secondary Metabolite Discovery in Streptomyces

CRISPR-aided genome engineering for secondary metabolite biosynthesis in Streptomyces

Recent development of antiSMASH and other computational approaches to mine secondary metabolite biosynthetic gene clusters

Systems biology and biotechnology of Streptomyces species for the production of secondary metabolites

Genome mining for the search and discovery of bioactive compounds: The Streptomyces paradigm

Genome mining of biosynthetic and chemotherapeutic gene clusters in Streptomyces bacteria

Exploration and genome mining of natural products from marine Streptomyces

Engineering fungal secondary metabolism: a roadmap to novel compounds.

Discovery of novel secondary metabolites encoded in actinomycete genomes through coculture

Genome mining of rare actinomycetes and cryptic pathway awakening

Genome Mining Reveals Novel Biosynthetic Gene Clusters in Entomopathogenic Bacteria

Complete genome sequencing and in silico genome mining reveal the promising metabolic potential in Streptomyces strain CS-7

Advances and Challenges in CRISPR/Cas-Based Fungal Genome Engineering for Secondary Metabolite Production: A Review

Transcriptional regulators of secondary metabolite biosynthesis in Streptomyces

Comparative Genomic Insights into Secondary Metabolism Biosynthetic Gene Cluster Distributions of Marine Streptomyces

Recent Advances in Strategies for Activation and Discovery/Characterization of Cryptic Biosynthetic Gene Clusters in Streptomyces

Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and other actinomycetes

Exploring Newer Biosynthetic Gene Clusters in Marine Microbial Prospecting